Meds & supplements › Tirofiban
Medicine
Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Tirofiban hydrochloride injection is contraindicated in patients with:
Concomitant use of fibrinolytics, anticoagulants and antiplatelet drugs increases the risk of bleeding.
sofidex [Internet]. Daloreum; c2026. Tirofiban; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/tirofiban
sofidex. (2026, August 3). Tirofiban. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/tirofiban
Tirofiban. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/tirofiban
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.